Article Data

  • Views 654
  • Dowloads 138

Case Reports

Open Access

Follicular variant of thyroid papillary carcinoma arising from ovarian mature cystic teratoma: a case report

  • Dae-Hyung Lee1,*,

1Department of Obstetrics & Gynecology, College of Medicine, Yeungnam University Medical Center, Daegu, 42415, Republic of Korea

DOI: 10.31083/j.ejgo.2020.06.2211 Vol.41,Issue 6,December 2020 pp.1056-1060

Submitted: 04 August 2020 Accepted: 28 August 2020

Published: 15 December 2020

*Corresponding Author(s): Dae-Hyung Lee E-mail: leebhy@ynu.ac.kr

Abstract

Malignant transformation of mature cystic teratoma of the ovary occurs very rarely. As reported in previously published literature, the incidence of malignant transformation is less than 2%. Among them, squamous cell carcinoma is the most common neoplasm; however, a follicular variant of thyroid papillary carcinoma arising from mature cystic teratoma is extremely rare. Here, I have reported a case of a follicular variant of thyroid papillary carcinoma arising from a mature ovarian cystic teratoma. A 65-year-old woman presented to our hospital for an incidentally detected ovarian mass. The patient underwent laparoscopic salpingo-oophorectomy for a suspicion of benign ovarian mass. Postoperative pathologic examination revealed a follicular variant of papillary carcinoma arising in the thyroid tissue of a mature ovarian cystic teratoma. Therefore, this case highlights that there is a possibility of an unusual but malignant transformation in ovarian teratoma.


Keywords

Mature cystic teratoma; Papillary thyroid carcinoma; Ovarian neoplasm.


Cite and Share

Dae-Hyung Lee. Follicular variant of thyroid papillary carcinoma arising from ovarian mature cystic teratoma: a case report. European Journal of Gynaecological Oncology. 2020. 41(6);1056-1060.

References

[1] Lai P., Hsieh S., Chien J.C., Fang C., Chan W.P., Yu C.: “Malignant transformation of an ovarian mature cystic teratoma: computed tomography findings”. Arch. Gynecol. Obstet., 2005, 271, 355-357.

[2] Yamaguchi K., Mandai M., Fukuhara K., Higuchi T., Hamanishi J., Takakura K., et al.: “Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period”. Oncol. Rep., 2008, 19, 705-711.

[3] Al-Rayyan E.S., Duqoum W.J., Sawalha M.S., Nascimento M.C., Pather S., Dalrymple C.J., et al.: “Secondary malignancies in ovarian dermoid cyst”. Saudi Med. J., 2009, 30, 524-528.

[4] Tangjitgamol S., Manusirivithaya S., Sheanakul C., Leelahakorn S., Thawaramara T., Jesadapatarakul S.: “Squamous cell carcinoma arising from dermoid cyst: case reports and review of literature”. Int. J. Gynecol. Cancer, 2003, 13, 558-563.

[5] Kelley R.R., Scully R.E.: “Cancer developing in dermoid cysts of the ovary - a report of 8 cases, including a carcinoid and a leiomyosarcoma”. Cancer, 1961, 14, 989-1000.

[6] Climie A.R.W., Heath L.P.: “Malignant degeneration of benign cys-tic teratomas of the ovary. Review of the literature and report of a chondrosarcoma and carcinoid tumor”. Cancer, 1968, 22, 824-832.

[7] Peterson W.F.: “Malignant degradation of benign cystic teratomas of the ovarya collective review of the literature”. Obstet. Gynecol. Surv., 1957, 12, 793-830.

[8] Kikkawa F., Nawa A., Tamakoshi K., Ishikawa H., Kuzuya K., Sug-anuma N., et al.: “Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary”. Cancer, 1998, 82, 2249-2255.

[9] Tseng C., Chou H., Huang K., Chang T., Liang C., Lai C., et al.: “Squamous cell carcinoma arising in mature cystic teratoma of the ovary”. Gynecol. Oncol., 1996, 63, 364-370.

[10] Chiang A.J., Chen M.Y., Weng C.S., Lin H., Lu C.H., Wang P.H., et al.: “Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: A Taiwanese gynecologic oncology group (TGOG) study”. J. Gynecol. Oncol., 2017, 28, e69.

[11] Dos Santos L., Mok E., Iasonos A., Park K., Soslow R.A., Aghajanian C., et al.: “Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature”. Gynecol. Oncol., 2007, 105, 321-324.

[12] Kashimura M., Shinohara M., Hirakawa T., Kamura T., Matsukuma K.: “Clinicopathologic study of squamous cell carcinoma of the ovary”. Gynecol. Oncol., 1989, 34, 75-79.

[13] Von Kahlden C.: “Ueber eine Eigenthumliche Form des Ovarialcar-cinoms”. Zentralbl allg Path., 1895, 7, 257.

[14] Rim S.M., Kim S.M., Choi H.S.: “Malignant transformation of ovarian mature cystic teratoma”. Int. J. Gynecol. Cancer, 2006, 16, 140- 144.

[15] Dane C., Ekmez M., Karaca A., Ak A., Dane B.: “Follicular variant of papillary thyroid carcinoma arising from a dermoid cyst: a rare malignancy in young women and review of the literature”. Taiwan. J. Obstet. Gynecol., 2012, 51, 421-425.

[16] Hong K., Han A.K.W., Kim M., Yun B.S., Jun H.S., Seong S.J., et al.: “Successful in vitro fertilization pregnancy and delivery after a fertility-sparing laparoscopic operation in a patient with a papillary thyroid carcinoma arising from a mature cystic teratoma”. Clin. Exp. Reprod. Med., 2019, 46, 140-145.

[17] Cokmez H., Gulbahar A., Yigit S., Aydin C.: “Oncocytic and tall columnar type papillary thyroid carcinoma arising on a mature cystic teratoma: a case report and literature review”. J. Pak. Med. Assoc., 2019, 69, 116-119.

[18] Iwahashi N., Deguchi Y., Horiuchi Y., Noguchi T., Yahata T., Ota N., et al.: “Live birth following laparoscopic fertility‑sparing surgery for papillary thyroid carcinoma arising from mature ovarian cystic teratoma: a case report”. Mol. Clin. Oncol., 2018, 9, 613-616.

[19] Kurman R., Telinde R.: “Blaustein’s pathology of the female genital tract”. 5th ed. New York: Springer Verlag, 2002.

[20] Park S.B., Kim J.K., Kim K.R., Cho K.S.: “Preoperative diagnosis of mature cystic teratoma with malignant transformation: analysis of imaging findings and clinical and laboratory data”. Arch. Gynecol. Obstet., 2007, 275, 25-31.

[21] DeSimone C.P., Lele S.M., Modesitt S.C.: “Malignant strumaovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy”. Gynecol. Oncol., 2003, 89, 543-548.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top